Disclosure of Safety and Efficacy Endpoints in Clinical Trial Registries
Disclosure of Safety and Efficacy Endpoints in Clinical Trial Registries How to Disclose Safety and Efficacy Endpoints in Clinical Trial Registries Introduction: Why Endpoint Transparency Is Mandatory Global regulations require sponsors to publicly disclose safety and efficacy endpoints of completed clinical trials. This mandate ensures scientific integrity, supports patient trust, and enhances public access to…
Read More “Disclosure of Safety and Efficacy Endpoints in Clinical Trial Registries” »